HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc.
Previous close
$5.21
Day range
$4.80 - $5.31
Year range
$2.70 - $9.97
Market cap
222.62M USD
Avg Volume
81.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.77M | 37.88% |
Operating expense | 7.02M | -10.68% |
Net income | -24.11M | 16.55% |
Net profit margin | -417.85 | 39.48% |
Earnings per share | -0.57 | 17.39% |
EBITDA | -24.61M | 20.72% |
Effective tax rate | -8.98% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 234.06M | -32.31% |
Total assets | 285.92M | -29.38% |
Total liabilities | 363.11M | -10.29% |
Total equity | -77.19M | — |
Shares outstanding | 42.57M | — |
Price to book | -2.85 | — |
Return on assets | -21.24% | — |
Return on capital | 300.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.11M | 16.55% |
Cash from operations | -27.54M | 4.78% |
Cash from investing | 37.38M | 674.54% |
Cash from financing | 186.00K | 1,062.50% |
Net change in cash | 10.03M | 128.32% |
Free cash flow | -6.34M | 60.91% |
About
Founded
2015
Website
Employees
116